Mehmood Khan

A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

Ronald Goldberg, David M. Kendall, Mark A. Deeg et al. · Diabetes Care · 2005 · 795 citations · Full text

Medicine, Endocrinology, Pharmacology +14

The Prevalence of Cardiac Valvular Insufficiency Assessed by Transthoracic Echocardiography in Obese Patients Treated with Appetite-Suppressant Drugs

Mehmood Khan, Charles A. Herzog, John V. St. Peter et al. · New England Journal of Medicine · 1998 · 267 citations · Full text

Medicine, Cardiology, Pharmacology +16

A Prospective, Randomized Comparison of the Metabolic Effects of Pioglitazone or Rosiglitazone in Patients With Type 2 Diabetes Who Were Previously Treated With Troglitazone

Mehmood Khan, John V. St. Peter, Jay L. Xue · Diabetes Care · 2002 · 248 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia

Mark A. Deeg, John B. Buse, Ronald Goldberg et al. · Diabetes Care · 2007 · 179 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes

A. R. Diani, Geri A. Sawada, B. M. Wyse et al. · American Journal of Physiology-Endocrinology and Metabolism · 2004 · 101 citations

Medicine, Endocrinology, Pharmacology +17